liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Human skin-resident CD8+T cells require RUNX2 and RUNX3 for induction of cytotoxicity and expression of the integrin CD49a
Karolinska Inst, Sweden.
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden; Univ Copenhagen, Denmark.
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden; Univ Copenhagen, Denmark.
Karolinska Inst, Sweden.
Show others and affiliations
2023 (English)In: Immunity, ISSN 1074-7613, E-ISSN 1097-4180, Vol. 56, no 6, p. 1285-1302.e7Article in journal (Refereed) Published
Abstract [en]

The integrin CD49a marks highly cytotoxic epidermal-tissue-resident memory (TRM) cells, but their differen-tiation from circulating populations remains poorly defined. We demonstrate enrichment of RUNT family tran-scription-factor-binding motifs in human epidermal CD8+CD103+CD49a+ TRM cells, paralleled by high RUNX2 and RUNX3 protein expression. Sequencing of paired skin and blood samples revealed clonal overlap be-tween epidermal CD8+CD103+CD49a+ TRM cells and circulating memory CD8+CD45RA-CD62L+ T cells. In vitro stimulation of circulating CD8+CD45RA-CD62L+ T cells with IL-15 and TGF-b induced CD49a expres-sion and cytotoxic transcriptional profiles in a RUNX2-and RUNX3-dependent manner. We therefore identi-fied a reservoir of circulating cells with cytotoxic TRM potential. In melanoma patients, high RUNX2, but not RUNX3, transcription correlated with a cytotoxic CD8+CD103+CD49a+ TRM cell signature and improved pa-tient survival. Together, our results indicate that combined RUNX2 and RUNX3 activity promotes the differ-entiation of cytotoxic CD8+CD103+CD49a+ TRM cells, providing immunosurveillance of infected and malig-nant cells.

Place, publisher, year, edition, pages
CELL PRESS , 2023. Vol. 56, no 6, p. 1285-1302.e7
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:liu:diva-197435DOI: 10.1016/j.immuni.2023.05.003ISI: 001025956400001PubMedID: 37269830OAI: oai:DiVA.org:liu-197435DiVA, id: diva2:1794077
Note

Funding Agencies|Novartis; European Union Marie Sklodowska-Curie Actions Postdoctoral Fellowship; KI Foundation grant; Swedish Research Council; Ragnar Soederberg Stiftelse; Svenska Lakaresallskapet; Stockholm County Council; Psoriasisfonden; Hudfonden; Swedish Cancer Foundation; Goeran Gustafsson Foundation; Karolinska Institutet Center for Innovative Medicine; Wallenberg Foundation

Available from: 2023-09-04 Created: 2023-09-04 Last updated: 2024-05-03

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Haapaniemi, Staffan

Search in DiVA

By author/editor
Haapaniemi, StaffanKeita, Åsa
By organisation
Department of Surgery in NorrköpingFaculty of Medicine and Health SciencesDivision of Surgery, Orthopedics and Oncology
In the same journal
Immunity
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 151 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf